ArticleBiomedicines2021

Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs.

Elmira Vagapova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.